Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-04-24 |
2024-03 |
0.64 |
N/A |
N/A |
N/A |
2024-02-06 |
2023-12 |
0.64 |
0.64 |
N/A |
N/A |
2023-10-25 |
2023-09 |
0.59 |
0.59 |
N/A |
N/A |
2023-07-26 |
2023-06 |
0.65 |
0.66 |
0.01 |
1.54% |
2023-04-26 |
2023-03 |
0.61 |
0.62 |
0.01 |
1.64% |
2023-01-31 |
2022-12 |
0.61 |
0.64 |
0.03 |
4.92% |
Date |
Firm |
Action |
From |
To |
2023-10-15 |
Leerink Partners |
Upgrade |
|
Market Perform |
2023-10-01 |
Citigroup |
Upgrade |
Buy |
Buy |
2023-09-25 |
Oppenheimer |
Upgrade |
Perform |
Outperform |
2023-09-07 |
Piper Sandler |
Upgrade |
Neutral |
Neutral |
2023-08-16 |
RBC Capital |
Upgrade |
Outperform |
Outperform |
2023-07-31 |
RBC Capital |
Upgrade |
Outperform |
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2024-03-12 |
BOBO DONALD E JR |
Officer |
213.20K |
Sale |
2024-02-20 |
CHOPRA DAVEEN |
Officer |
22.75K |
Sale |
2024-02-22 |
GALLAHUE KIERAN T. |
Director |
70.92K |
Stock Gift |
2024-03-10 |
LEMERCIER JEAN-LUC M |
Officer |
173.58K |
Sale |
2024-03-06 |
LIPPIS DANIEL J |
Officer |
17.21K |
Sale |
2024-03-03 |
MUSSALLEM MICHAEL A |
Director |
4.04M |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
51.31M |
4.84B |
8.44% |
2023-06-29 |
Blackrock Inc. |
50.81M |
4.79B |
8.36% |
2023-06-29 |
State Street Corporation |
27.05M |
2.55B |
4.45% |
2023-06-29 |
Capital International Investors |
27.02M |
2.55B |
4.44% |
2023-06-29 |
Alliancebernstein L.P. |
20.51M |
1.93B |
3.37% |
2023-06-29 |
Bank Of New York Mellon Corporation |
17.71M |
1.67B |
2.91% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
18.92M |
1.78B |
3.11% |
2023-06-29 |
Vanguard 500 Index Fund |
14.43M |
1.36B |
2.37% |
2023-07-30 |
Vanguard Specialized-Health Care Fund |
9.39M |
770.32M |
1.54% |
2023-05-30 |
Fidelity 500 Index Fund |
6.92M |
582.74M |
1.14% |
2023-08-30 |
SPDR S&P 500 ETF Trust |
6.68M |
510.77M |
1.10% |
2023-06-29 |
Growth Fund Of America Inc |
6.63M |
624.95M |
1.09% |
Split |
Date |
3 : 1 |
2020-06-01 |
2 : 1 |
2015-12-14 |
2 : 1 |
2010-05-28 |
1 : 1 |
2010-05-27 |